Status:
UNKNOWN
The Marginal Bone Loss in Dental Implants
Lead Sponsor:
Hospital Universitari de Bellvitge
Conditions:
Dental Implants
Eligibility:
All Genders
Phase:
NA
Brief Summary
When an implant is placed, it is assumed that there will be a loss of bone in the more coronal area around it. The placement of the implant in relation to bone level, either crestal or subcrestal and ...
Detailed Description
Implant dentistry has undergone major development and expansion since the nineteen sixties, when Dr. Branemark (Sweden) introduced the concept of osseointegration. The use of implants to replace missi...
Eligibility Criteria
Inclusion
- Patients of general age who present partial edentulism in the mandible and / or maxilla and require the replacement of at least 2 teeth by implants in the same maxilla.
- The teeth must have been removed at least 4-6 months before implant placement.
- The minimum required bone height would be 6mm, which would be determined by an orthopantomography (1: 1)
Exclusion
- History of use of bisphosphonates
- Evidence of serious systemic diseases such as recent infarction
- Uncontrolled diabetes, coagulation disorders, cancer, psychiatric contraindications,
- Active infection in the area of the implants
- Absence of an antagonist in the area of implant placement
- Pharmacological treatments capable of affecting gingival health
- Pregnant or lactating women.
Key Trial Info
Start Date :
May 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 17 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03232372
Start Date
May 8 2017
End Date
February 17 2022
Last Update
September 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natalia Palacios Garzon
Barcelona, Spain, 08232